Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.
We slightly increased the company's growth estimates on the heels of the Capital Markets Day (CMD) and lowered our required return for the share by one notch.
Scanfil will arrange a CMD event on 29-30 September 2026 and M&A activity will become a bigger part of the company's equity story. The company also raised its long-term growth target to 15% (old 10%). New net debt per EBITDA get is 1-2x (old below 1....
Scanfil will arrange a CMD event on 29-30 September 2026. We expect the company's long-term revenue growth target of 10% and its EBITA margin target of 7-8% to remain unchanged. The main focus of the CMD could be related to the newest MB Elettronica ...
Raising the guidance due to continued strong demand and improved visibility into supply chains was no surprise to the market, as the company's H1 was strong relative to the old guidance.
Net sales and adjusted EBITA were close to LSEG consensus in Q2. Scanfil kept its full-year outlook intact, but we trim our Q3 estimates and upgrade our forecasts for Q4. Net sales growth could exceed 25% this year. Overall, we consider the risks to ...
The company's outlook is positive in both the short and longer term, and the stock's valuation has also decreased slightly in recent weeks (2026e: adj. EV/EBITA 12x).
Net sales and adjusted EBITA were around 1% above market consensus (LSEG) in Q2. Reported growth of 28% y/y was supported by acquisitions. Scanfil’s profitability (EBITA margin) remained healthy in Q2. Organic growth was 5% in the quarter, with the Americas...
